MRP1 can transport chemotherapeutic drugs coupled with reduced glutathione against the concentration gradient and reduce the concentration of chemotherapeutic drugs in tumor cells, thus allowing tumor cells to develop drug resistance. Here, ABCC1 is linked to neoplasm.